Universal Beteiligungs und Servicegesellschaft mbH Acquires New Holdings in Teleflex Incorporated (NYSE:TFX)

Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Teleflex Incorporated (NYSE:TFX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 36,679 shares of the medical technology company's stock, valued at approximately $6,528,000. Universal Beteiligungs und Servicegesellschaft mbH owned 0.08% of Teleflex as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the stock. Jefferies Financial Group Inc. increased its stake in shares of Teleflex by 9.3% during the fourth quarter. Jefferies Financial Group Inc. now owns 4,837 shares of the medical technology company's stock worth $861,000 after purchasing an additional 412 shares during the period. Mackenzie Financial Corp increased its position in Teleflex by 59.2% during the 4th quarter. Mackenzie Financial Corp now owns 36,281 shares of the medical technology company's stock worth $6,457,000 after buying an additional 13,488 shares during the period. Forum Financial Management LP increased its position in Teleflex by 48.6% during the 4th quarter. Forum Financial Management LP now owns 1,293 shares of the medical technology company's stock worth $230,000 after buying an additional 423 shares during the period. Toronto Dominion Bank lifted its holdings in shares of Teleflex by 5.9% during the fourth quarter. Toronto Dominion Bank now owns 24,961 shares of the medical technology company's stock worth $4,443,000 after buying an additional 1,395 shares in the last quarter. Finally, GF Fund Management CO. LTD. bought a new stake in shares of Teleflex in the fourth quarter valued at about $234,000. 95.62% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms recently commented on TFX. Truist Financial lowered their price target on shares of Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a research report on Monday, May 5th. Mizuho set a $155.00 target price on shares of Teleflex in a research report on Wednesday, April 16th. Wall Street Zen downgraded shares of Teleflex from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. Morgan Stanley cut their price target on Teleflex from $191.00 to $173.00 and set an "overweight" rating for the company in a research note on Monday, May 5th. Finally, Royal Bank of Canada lowered their price objective on Teleflex from $150.00 to $145.00 and set a "sector perform" rating on the stock in a research note on Friday, May 2nd. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $164.63.

Teleflex Price Performance

Shares of NYSE TFX traded up $1.39 during trading hours on Wednesday, hitting $122.83. 376,076 shares of the stock were exchanged, compared to its average volume of 626,090. The company's fifty day simple moving average is $128.53 and its two-hundred day simple moving average is $156.02. The company has a market cap of $5.43 billion, a PE ratio of 24.42, a price-to-earnings-growth ratio of 1.73 and a beta of 1.17. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a 1-year low of $118.70 and a 1-year high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last issued its earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, beating analysts' consensus estimates of $2.88 by $0.03. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $700.67 million for the quarter, compared to the consensus estimate of $699.37 million. During the same quarter last year, the business posted $3.21 EPS. The company's revenue was down 5.0% compared to the same quarter last year. On average, sell-side analysts predict that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Tuesday, May 20th will be given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 1.11%. The ex-dividend date is Tuesday, May 20th. Teleflex's dividend payout ratio is presently 42.90%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.